Free Trial

Rhythm Pharmaceuticals (RYTM) SEC Filings & 10K Form

$50.02
+3.42 (+7.34%)
(As of 07/12/2024 ET)

Recent Rhythm Pharmaceuticals SEC Filings

DateFilerForm TypeView
07/10/2024
4:00 PM
Garfield Alastair (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
07/10/2024
4:01 PM
Garfield Alastair (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/10/2024
3:05 PM
Rhythm Pharmaceuticals (Filer)
Form 424B7
07/10/2024
3:07 PM
Rhythm Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/25/2024
3:39 PM
MCGIRR DAVID W J (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2024
3:41 PM
Arbuckle Stuart A (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2024
3:30 PM
GOOD JENNIFER L (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2024
3:35 PM
JEAN CHRISTOPHE (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2024
3:37 PM
Bedrosian Camille L (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2024
3:38 PM
Mathers Edward T (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2024
3:38 PM
Rhythm Pharmaceuticals (Issuer)
TETRAULT LYNN A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
8:44 PM
MCGIRR DAVID W J (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
8:47 PM
Rhythm Pharmaceuticals (Issuer)
TETRAULT LYNN A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
8:38 PM
Arbuckle Stuart A (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
8:39 PM
GOOD JENNIFER L (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
8:41 PM
Bedrosian Camille L (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
8:42 PM
JEAN CHRISTOPHE (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
8:43 PM
Mathers Edward T (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2024
4:28 PM
Rhythm Pharmaceuticals (Filer)
Form DEFA14A
06/17/2024
4:19 PM
Rhythm Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/07/2024
3:43 PM
Rhythm Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/07/2024
6:10 AM
Rhythm Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/30/2024
6:31 PM
NEW ENTERPRISE ASSOCIATES 13 LP (Filed by)
Rhythm Pharmaceuticals (Subject)
Form SC 13D/A
04/26/2024
3:13 PM
Rhythm Pharmaceuticals (Filer)
Form ARS
04/17/2024
3:15 PM
PERCEPTIVE ADVISORS LLC (Filed by)
Rhythm Pharmaceuticals (Subject)
Form SC 13D/A
04/16/2024
7:11 PM
Mazabraud Yann (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/16/2024
6:00 AM
Rhythm Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/03/2024
7:00 PM
German Christopher Paul (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2024
5:18 PM
PERCEPTIVE ADVISORS LLC (Filed by)
Rhythm Pharmaceuticals (Subject)
Form SC 13D/A
04/01/2024
4:25 PM
Rhythm Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/22/2024
3:55 PM
Rhythm Pharmaceuticals (Issuer)
Shulman Joseph (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/21/2024
3:21 PM
Rhythm Pharmaceuticals (Subject)
Shulman Joseph (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/20/2024
4:51 PM
PERCEPTIVE ADVISORS LLC (Filed by)
Rhythm Pharmaceuticals (Subject)
Form SC 13D
03/20/2024
3:41 PM
Lee Jennifer Kayden (Reporting)
Rhythm Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/19/2024
7:50 PM
Cramer Pamela J. (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2024
7:52 PM
Lee Jennifer Kayden (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2024
7:53 PM
Mazabraud Yann (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2024
7:54 PM
Meeker David P (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2024
7:56 PM
Rhythm Pharmaceuticals (Issuer)
Shulman Joseph (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2024
7:57 PM
Rhythm Pharmaceuticals (Issuer)
Smith Hunter C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/29/2024
3:58 PM
Rhythm Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
This is the type of environment we pray for… (Ad)

There is a situation in the market right now that requires your immediate attention. It involves a company that has $9 billion in cash, only $500,000 in debt, and a market cap of around $8 billion. This may not mean much to you right now.

I’ve spent months preparing this content for you.
02/29/2024
3:44 PM
Rhythm Pharmaceuticals (Filer)
Form 424B5
02/29/2024
3:46 PM
Rhythm Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/29/2024
3:05 PM
Rhythm Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/22/2024
6:01 AM
Rhythm Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/21/2024
6:00 PM
Lee Jennifer Kayden (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2024
6:00 PM
Rhythm Pharmaceuticals (Issuer)
Shulman Joseph (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2024
6:01 PM
Rhythm Pharmaceuticals (Issuer)
Smith Hunter C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2024
6:01 PM
Cramer Pamela J. (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2024
6:02 PM
German Christopher Paul (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2024
6:02 PM
Mazabraud Yann (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2024
6:03 PM
Meeker David P (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/15/2024
5:14 PM
Rhythm Pharmaceuticals (Issuer)
Shulman Joseph (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2024
7:45 PM
Cramer Pamela J. (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2024
7:46 PM
Rhythm Pharmaceuticals (Issuer)
Shulman Joseph (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2024
7:47 PM
Lee Jennifer Kayden (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2024
7:49 PM
Mazabraud Yann (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2024
7:50 PM
Rhythm Pharmaceuticals (Issuer)
Smith Hunter C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2024
4:13 PM
Rhythm Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G
02/09/2024
3:19 PM
Rhythm Pharmaceuticals (Subject)
Shulman Joseph (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/05/2024
5:53 PM
Cramer Pamela J. (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2024
5:53 PM
Meeker David P (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2024
5:54 PM
Rhythm Pharmaceuticals (Issuer)
Shulman Joseph (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2024
5:54 PM
Rhythm Pharmaceuticals (Issuer)
Smith Hunter C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2024
5:55 PM
Lee Jennifer Kayden (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2024
4:34 PM
GOLDMAN SACHS GROUP INC (Filed by)
GOLDMAN SACHS GROUP INC (Filed by)
Rhythm Pharmaceuticals (Subject)
Form SC 13G/A
01/24/2024
8:46 AM
BlackRock Inc. (Filed by)
Rhythm Pharmaceuticals (Subject)
Form SC 13G/A
01/23/2024
8:04 AM
Rhythm Pharmaceuticals (Subject)
STATE STREET CORP (Filed by)
Form SC 13G/A
01/04/2024
6:15 AM
Rhythm Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/04/2024
6:00 AM
Rhythm Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/03/2024
3:15 PM
Rhythm Pharmaceuticals (Issuer)
Smith Hunter C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/29/2023
3:30 PM
Rhythm Pharmaceuticals (Issuer)
Shulman Joseph (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/27/2023
3:22 PM
Rhythm Pharmaceuticals (Subject)
Shulman Joseph (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/18/2023
3:16 PM
Rhythm Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/06/2023
3:30 PM
Rhythm Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/06/2023
3:34 PM
Rhythm Pharmaceuticals (Subject)
Smith Hunter C (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/24/2023
12:06 PM
Rhythm Pharmaceuticals (Subject)
Smith Hunter C (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/14/2023
3:14 PM
Lee Jennifer Kayden (Reporting)
Rhythm Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/14/2023
3:14 PM
Rhythm Pharmaceuticals (Subject)
Shulman Joseph (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/13/2023
4:44 PM
Lee Jennifer Kayden (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/08/2023
3:30 PM
Rhythm Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/08/2023
3:14 PM
Lee Jennifer Kayden (Reporting)
Rhythm Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/07/2023
5:17 PM
Lee Jennifer Kayden (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/07/2023
6:05 AM
Rhythm Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/03/2023
3:24 PM
Lee Jennifer Kayden (Reporting)
Rhythm Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/07/2023
4:48 PM
Lee Jennifer Kayden (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/07/2023
9:14 AM
FEDERATED HERMES, INC. (Filed by)
FEDERATED HERMES, INC. (Filed by)
Rhythm Pharmaceuticals (Subject)
Form SC 13G/A
09/05/2023
3:17 PM
Lee Jennifer Kayden (Reporting)
Rhythm Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/21/2023
3:30 PM
Rhythm Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/16/2023
4:50 PM
German Christopher Paul (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
08/08/2023
6:32 AM
Rhythm Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
This is the type of environment we pray for… (Ad)

There is a situation in the market right now that requires your immediate attention. It involves a company that has $9 billion in cash, only $500,000 in debt, and a market cap of around $8 billion. This may not mean much to you right now.

I’ve spent months preparing this content for you.
08/01/2023
3:27 PM
Rhythm Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/01/2023
6:05 AM
Rhythm Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/28/2023
8:01 PM
Cramer Pamela J. (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:RYTM) was last updated on 7/13/2024 by MarketBeat.com Staff

From Our Partners